Evidence map›Paper›PMID 38099532›Full record

SynthesisCurrent drug delivery2024

Liposomal Doxorubicin

Pablo Redruello-Guerrero, Paula Córdoba-Peláez, Antonio Jesús Láinez-Ramos-Bossini, Mario Rivera-Izquierdo, Cristina Mesas, Raul Ortiz, Jose Prados, Gloria Perazzoli

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Current drug delivery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pablo Redruello-GuerreroInstitute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain.ORCID 0000-0001-9992-5801
Paula Córdoba-PeláezFaculty of Medicine, University of Málaga, 29010 Málaga, Spain.
Antonio Jesús Láinez-Ramos-BossiniDepartment of Radiology, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain.ORCID 0000-0002-0663-2856
Mario Rivera-IzquierdoDepartment of Preventive Medicine and Public Health, Faculty of Medicine, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-6159-6037
Cristina MesasInstitute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain.ORCID 0000-0001-6369-5485
Raul OrtizInstitute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain.ORCID 0000-0001-8409-5235
Jose PradosInstitute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain.ORCID 0000-0003-4303-7746
Gloria PerazzoliInstitute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, 18100 Granada, Spain.ORCID 0000-0003-2205-749X
Universidad de Granada · ESHospital Universitario Virgen de las Nieves · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiposomal Doxorubicin (Doxil

methodsA total of 1022 articles were identified in publications up to 2020 (MEDLINE, Cochrane, Web of Science Core Collection and Scopus). After applying inclusion criteria, the number was restricted to 114, of which 48 assays, including

resultsThe maximum inhibitory concentration (IC

conclusionDoxil

Indexed as

Antibiotics, AntineoplasticCarcinoma, Non-Small-Cell LungDoxorubicinLung NeoplasmsAnimalsCell ProliferationHumansLiposomesPolyethylene GlycolsAntibiotics, AntineoplasticDoxorubicinliposomal doxorubicinLiposomesPolyethylene Glycolscaelyxclinical trialDoxil®in vivo assaymyocetnon-small lung cancersystematic review.

Identifiers

PMID38099532
OpenAlexW4389802967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.